Featured Research

from universities, journals, and other organizations

Nothin' to sneeze at: New treatment for common allergies

Date:
October 3, 2013
Source:
McMaster University
Summary:
Researchers have successfully tested treatments for people with allergies to grasses and to dust mites. The treatments are from a new class of therapy, known as ‘synthetic peptide immuno-regulatory epitopes’, or SPIREs. Positive results, first with a cat allergy therapy and now with house dust mite and grass allergy treatments, suggest that this approach may be used for many common allergies.

Researchers have successfully tested treatments for people with allergies to grasses and to dust mites.
Credit: © luna / Fotolia

Researchers have successfully tested treatments for people with allergies to grasses and to dust mites.

There are two treatments, one for grass allergy, which is commonly known as hay fever, and the other for dust mite allergy. They are expected to be helpful for the millions of people who, as a reaction to grass pollen or the tiny bugs that live in house dust, have sneezing, itching eyes and a running nose that often significantly impacts their productivity at school or work.

The two studies were conducted by Adiga Life Sciences, a joint venture between McMaster University and Circassia, a U.K. based biotechnology company, and was supported by St. Joseph's Healthcare Hamilton.

It is estimated that together, these allergens are responsible for more than 50% of allergic respiratory disease. Between 15 and 25 per cent of the population in North America and Europe is sensitive to pollen from different grass species. One in four people is sensitized to house dust mites, more than any other common allergen, which includes millions of people in these regions.

The treatments are from a new class of therapy, known as 'synthetic peptide immuno-regulatory epitopes', or SPIREs.

The 280 patients in the phase two clinical trial for the grass allergy treatment recorded their allergy symptoms while exposed to grass pollen in a controlled environment, both before treatment and at the end of the hay fever season. Study participants received one of three treatment regimens over three months, completed prior to the beginning of the pollen season. Those who had the optimal short course of therapy had significantly improved symptoms at the end of the season, compared to those who had a placebo. This treatment, called Grass-SPIRE, was well tolerated.

During the clinical trial for the dust mite treatment, 172 patients who received four doses of the treatment over 12 weeks had significantly improved allergy symptoms a year after the start of treatment, compared to patients who received a placebo. The treatment, called HDM-SPIRE, was well tolerated.

"This result is an important validation of the approach we are taking to treat allergic diseases," said Mark Larchι, who led the design of the treatments. "Positive results, first with a cat allergy therapy and now with house dust mite and grass allergy treatments, suggest that this approach may be used for many common allergies."

Larchι is a professor of medicine of the Michael G. DeGroote School of Medicine at McMaster and member of the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton.

Hay fever is a seasonal response to many different grass pollens which are heaviest in the spring and fall.

Dust mites are close relatives of spiders and ticks and are too small to see without a microscope. They eat skin cells shed by people, and they thrive in warm, humid environments. Upholstered furniture, bedding and carpeting provide an ideal environment for dust mites.


Story Source:

The above story is based on materials provided by McMaster University. Note: Materials may be edited for content and length.


Cite This Page:

McMaster University. "Nothin' to sneeze at: New treatment for common allergies." ScienceDaily. ScienceDaily, 3 October 2013. <www.sciencedaily.com/releases/2013/10/131003111117.htm>.
McMaster University. (2013, October 3). Nothin' to sneeze at: New treatment for common allergies. ScienceDaily. Retrieved April 19, 2014 from www.sciencedaily.com/releases/2013/10/131003111117.htm
McMaster University. "Nothin' to sneeze at: New treatment for common allergies." ScienceDaily. www.sciencedaily.com/releases/2013/10/131003111117.htm (accessed April 19, 2014).

Share This



More Health & Medicine News

Saturday, April 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) — In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) — A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) — The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) — President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins